Abstract
Purpose: To evaluate the clinical effects of transcatheter arterial embolization (TAE) on malignant bone and soft tissue tumors.
Methods: TAE was performed in 10 patients with primary bone and soft tissue sarcomas and in 31 patients with metastatic bone tumors. The embolized arteries were the internal iliac artery in 30 cases, the intercostal artery in six cases, the lumbar artery in five cases, the suprascapular artery in three cases, and the iliolumbar artery, the internal pudendal artery, and the lateral sacral artery in one case each. The embolized material was gelatin sponge particles. The chemotherapeutic drugs were usually 20–40 mg of doxorubicin for primary and metastatic tumors and 50–100 mg of cisplatin only for primary tumors. In addition, 50–60 Gy of 10-MV radiotherapy with or without radiofrequency (RF)-capacitive hyperthermia in four sessions was administered before TAE for primary tumors only.
Results: Even though the pain score increased immediately after TAE, 30 of 38 (79%) patients with pain (8 of 9 with primary tumors, and 22 of 29 with metastases) achieved pain control after TAE. A necrotic low-density area shown by computed tomography (CT) after TAE was found in 31 of 41 (76%) tumors [8 of 10 (80%) with primary tumors, and 23 of 31 (74%) with metastatic tumors]. The tumor size decreased in 14 of 25 (56%) primary and metastatic tumors after 3 months. Osteosclerotic changes appeared in two cases of metastatic tumors after 6 months. In five tumors resected after TAE, large areas of necrosis within the tumor were confirmed histologically. Transient local pain and numbness appeared after TAE, but were relieved by drug treatment within 1 week. No severe complications except a case of gluteal muscle necrosis were encountered after TAE. The 1-year survival rate of the patients with primary tumors was 38.1%, and the median survival was 18 months. The longest survival was 84 months. The 1-year survival rate of the patients with metastatic bone tumors was 38.9%; the median survival was 12 months. The longest survival was 24 months.
Conclusion: TAE could be an effective treatment for pain control and local control of malignant bone and soft-tissue tumors.
Similar content being viewed by others
References
Yamada R, Kishi T, Sonomura T, Tsuda M, Nomura S, Satoh M (1990) Transcatheter arterial embolization in unresectable hepatocellular carcinoma. Cardiovasc Intervent Radiol 13:135–139
Uchida H, Oishi H, Matsuo N, Nishimine S, Ohue Y, Nishimura Y, Maeda M, Yoshioka T (1990) Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and gelfoam particles for hepatocellular carcinoma. Cardiovasc Intervent Radiol 13:140–145
Wallace S, Chuang VP, Swanson O (1981) Embolization for renal carcinoma. Radiology 138:563–570
Katzen BT, Said S (1981) Arteriovenous malformation of bone: An experience with therapeutic embolization. AJR 136:427–429
Nancarrow PA, Lock JE, Fellows KE (1986) Embolization of an intraosseous arteriovenous malformation. AJR 146:785–786
MacErlean DP, Shank DG, Martin EA (1978) Transcatheter embolization of bone tumor arteriovenous malformation. Br J Radiol 51:414–419
Tong D, Gellich L, Hendrichsen FR (1982) The palliation of symptomatic osseous metastases: Final treatment results of the study by the Radiation Therapy Oncology Group. Cancer 50:893–899
Wallace S, Graymeyeh M, Desantos LA, Murray JA, Romsdahl MM, Bracken RB (1979) Arterial occlusion of pelvic bone tumors. Cancer 43:322–328
Nagata Y, Nakano Y, Abe M, Takahashi M, Kohno S (1989) Osseous metastases from hepatocellular carcinoma: Embolization of pain control. Cardiovasc Intervent Radiol 12:149–153
Rowe DM, Becker GJ, Rabe FE (1984) Osseous metastasis from renal cell carcinoma: Embolization and surgery for restoration of function. Radiology 150:673–676
Lieberman PH, Brennan MF, Kimmel M, Erlandson RA, Garin-Chesa P, Flehinger BY (1989) Alveolar soft part sarcoma: A clinicopathologic study of a half a century. Cancer 63:1–13
Masuda H, Ogata T, Kikuchi K (1988) Pulmonary manifestations of alveolar soft part sarcoma: Bronchial arterial embolization for hemoptysis. Jpn J Cancer Chemother 5:2497–2500
Winkler K, Bielich S, Delling G, Salzer-Kuntschik M, Kotz R, Greenshaw C, Ritter J (1990) Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate and ifosfamide on histologic tumor response in osteosarcoma (Study COSS-86). Cancer 66:1703–1710
Bielach SS, Erttmann R, Looft G, Delling G, Winkler K, Landbeck G (1989) Platinum disposition after intraarterial and intravenous infusion of cisplatin for osteosarcoma. Cancer Chemother Pharmacol 24:376–380
Matsubayashi T, Koga H, Nishimura Y (1981) The reparative response of metastatic bone lesions after radiotherapy. Jpn J Clin Oncol 11:253–264
Libshitz HI, Horotobagyi GN (1981) Radiographic evaluation of therapeutic response in bony metastases of breast cancer. Skeletal Radiol 7:159–165
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nagata, Y., Mitsumori, M., Okajima, K. et al. Transacatheter arterial embolization for malignant osseous and soft tissue sarcomas. II. Clinical results. Cardiovasc Intervent Radiol 21, 208–213 (1998). https://doi.org/10.1007/s002709900246
Issue Date:
DOI: https://doi.org/10.1007/s002709900246